VIM and neoplasm: Strong positive correlations of vimentin levels were found between primary tumor sites, lymph node metastases, and the number of tumor buds (Pearson r = 0.90, r = 0.90 to 0.92; p < 0.001, p < 0.001), supporting its general use as a mesenchymal marker in the EMT process throughout all anatomical locations analyzed.